| Followers | 2421 |
| Posts | 92347 |
| Boards Moderated | 1 |
| Alias Born | 09/12/2003 |
Friday, June 30, 2023 7:35:19 PM
$BDPT SECURITY DETAILS: The company just now provided an update on the share count, confirming that the outstanding shares remain unchanged at 576,464,023. Interestingly, they have significantly accelerated their efforts in converting and paying off past notes. While they could have chosen to do this at any point within the next 1-2 years. In my opinion they have decided to clean up their books in preparation for the spin-off. This process has unfolded rapidly, especially around the time of announcing new board members, new products/patents/licensing agreements, and other significant developments. It appears that things are being "cleaned up" for a specific reason, and I perceive great potential in these actions. Only time will reveal the full extent of the outcome. Wishing everyone a pleasant weekend.
https://www.otcmarkets.com/stock/BDPT/overview
My calculation regarding the end of the dilution was accurate.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172180155
https://www.otcmarkets.com/stock/BDPT/overview
My calculation regarding the end of the dilution was accurate.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172180155
Bullish
Recent BDPT News
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:05:36 PM

